Tag Archives: specialty pharmacy

Specialty Drug

Buy and Bill Trend: Are there Contradictions to Vendor or Pharma’s Reported Data

Posted on by John Santilli

Buy and Bill Trend:  Are there Contradictions to Vendor or Pharma’s Reported Data Distribution based sales of specialty pharmaceuticals raises critical issues for manufacturers and providers as plan year 2016 decisions have been made and 2017 preparations begin by purchasers. For pharmaceutical manufacturers, the dilemma arises when (1) reimbursement is limited or eliminated under benefit […]

Continue reading →
Market Intelligence

Why CVS Recent Deals Change the Specialty Landscape

Posted on by John Santilli

Why CVS Recent Deals Change the Specialty Landscape – Following a similar path as in the late 1990’s with long term care pharmacy, specialty pharmacy has matured enough to undergo consolidation and roll-up into larger healthcare entities. Specialty represents a small distribution volume in the retail pharmacy space but also results in the greatest profit […]

Continue reading →
Specialty Drug

CVS Health Acquires Omnicare

Posted on by John Santilli

CVS Health Acquires Omnicare – Well, the guessing game is over as CVS Health acquires Omnicare. The Pharmacy in Long-Term Care market has a new industry leader as CVS Health will see if their business model translates to the long-term care pharmacy market. The LTC market is a different business and CVS is moving from their traditional “core competency”. It […]

Continue reading →
Affordable Care Act, Dr. Randy Vogenberg, John Santilli, Market Intelligence, Trends

Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New Marketplace

Posted on by aprilgregory

By John Santilli, MBA, and F. Randy Vogenberg, PhD, RPh After the passage of the Affordable Care Act (ACA) in 2010, market changes beyond those already in play began to emerge. Traditional roles, responsibilities, and authority could now be tested or altered as a result of some sections of the ACA. One result is that […]

Continue reading →
Market Intelligence

Contracting With Specialty Pharmacies (SPs) At Your Own Peril

Posted on by Dr. Randy

How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]

Continue reading →
Market Intelligence

Walgreens Specialty Pharmacy Exclusive Distributor for Three Sigma-Tau Drugs

Posted on by AMI
01
Aug

The deal includes Sigma-Tau’s Adagen (pegademase bovine), Cystaran (cysteamine ophthalmic solution), and Matulane (procarbazine hydrochloride). As a result of the agreement, each of these prescription drugs can now be obtained through Walgreens Specialty Pharmacy locations. Adagen is an intramuscular injection indicated for replacement therapy for adenosine deaminase (ADA) deficiency in patients with severe combined immunodeficiency […]

Continue reading →
Market Intelligence

CVS Caremark Acquires Navarro Discount Pharmacy

Posted on by AMI
15
Jul

CVS Caremark reached an agreement with Navarro, the largest Hispanic owned drugstore chain in the U.S., to acquire 33 stores and Navarro Health Services, a specialty pharmacy serving patients with complex or chronic diseases. CVS Caremark operates more than 7,600 stores, but said it will continue operating the acquired units under the Navarro banner. Navarro […]

Continue reading →
Market Report

Hepatitis C and Specialty Pharmacy Market

Posted on by aprilgregory

Express Scripts Plans a Specialty Drug Price War over new hepatitis C treatments reports a recent Bloomberg News story. The news follows the release of Gilead’s Sovaldi (sofosbuvir), which reportedly costs $1,000 per pill. Express Scripts projects that Hepatitis C drug trend will grow by 168% by 2015, so employers and health plan payers are […]

Continue reading →